Tema Oncology ETF (NASDAQ:CANC) Short Interest Up 232.7% in January

Tema Oncology ETF (NASDAQ:CANC) was the target of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 16,300 shares, a growth of 232.7% from the January 15th total of 4,900 shares. Based on an average daily trading volume, of 18,000 shares, the days-to-cover ratio is presently 0.9 days.

Tema Oncology ETF Stock Up 1.2 %

Shares of Tema Oncology ETF stock traded up $0.29 on Thursday, reaching $25.25. The company’s stock had a trading volume of 7,461 shares, compared to its average volume of 28,870. The company has a market capitalization of $64.38 million, a price-to-earnings ratio of 26.86 and a beta of 1.11. The firm’s fifty day simple moving average is $25.19 and its two-hundred day simple moving average is $27.23. Tema Oncology ETF has a 52 week low of $23.97 and a 52 week high of $30.11.

Tema Oncology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were issued a dividend of $0.7283 per share. The ex-dividend date was Wednesday, December 11th.

Institutional Trading of Tema Oncology ETF

An institutional investor recently raised its position in Tema Oncology ETF stock. Thrivent Financial for Lutherans boosted its stake in shares of Tema Oncology ETF (NASDAQ:CANC) by 25.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 399,509 shares of the company’s stock after acquiring an additional 80,133 shares during the quarter. Thrivent Financial for Lutherans owned about 22.96% of Tema Oncology ETF worth $11,351,000 as of its most recent SEC filing.

About Tema Oncology ETF

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.